Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Monday, January 12, 2026, in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference. https://mma.prnewswire.com/media/678850/Neurocrine_Biosciences_Logo.jpg The live presentation will be webcast and can be accessed on Neurocrine Biosciences' website under Investors […]